Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Interest Coverage Ratio (2019 - 2025)

BridgeBio Pharma's Interest Coverage Ratio history spans 7 years, with the latest figure at 3.63 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 134.59% year-over-year to 3.63; the TTM value through Dec 2025 reached 9.86, down 51.25%, while the annual FY2025 figure was 9.86, 51.25% down from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 3.63 at BridgeBio Pharma, up from 12.37 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 3.63 in Q4 2025 and bottomed at 17.2 in Q1 2021.
  • The 5-year median for Interest Coverage Ratio is 7.71 (2023), against an average of 7.35.
  • The largest YoY upside for Interest Coverage Ratio was 134.59% in 2025 against a maximum downside of 17047.93% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 10.94 in 2021, then skyrocketed by 40.92% to 6.46 in 2022, then plummeted by 35.4% to 8.75 in 2023, then dropped by 19.98% to 10.5 in 2024, then skyrocketed by 134.59% to 3.63 in 2025.
  • Per Business Quant, the three most recent readings for BBIO's Interest Coverage Ratio are 3.63 (Q4 2025), 12.37 (Q3 2025), and 3.57 (Q2 2025).